Loading... Please wait...
About Us
Contact Us
Privacy Policy
Sign in
or
Create an account
My Account
View Cart
Checkout
Search
Home
Report Subject
Medical Affairs
Browse by
Biosimilar Index
Dossier
FirstView
FirstView NPS+
FirstWord Pharma
Therapy Trends
Therapy Trends Updates
Latest Reports
Therapy Area Reports
Report Subject
Emerging Markets
Generics/Biosimilars
Market Access
Medical Affairs
Pharma Marketing
Pharma Sales
Technology/Digital Health
Orphan Drugs
Sort by:
Featured Items
Newest Items
Bestselling
Alphabetical: A to Z
Alphabetical: Z to A
FirstWord Medical Affairs Reports
Next »
Pages:
1
2
3
4
Learn More
Market Access Team Structure and Function (2020)
How are market access teams achieving success in today's challenging market? In the light of unprecedented operational challenges, the pressure on market access teams continues to build as the specific needs of multiple...
Compare
Learn More
Trends in Digital Pharma Marketing (2020)
How has COVID-19 impacted pharma digital marketing activity—now and for the future? The effects of coronavirus on pharma marketing budgets, priorities and actions cannot be ignored. During the pandemic, pharma...
Compare
Learn More
Digital Biomarkers: Pharma’s clinical development future?
Assessing digital biomarker applications that could radically impact pharma's clinical research practice By precisely and continuously measuring disease symptoms, digital biomarkers can allow pharma to establish valid...
Compare
Learn More
The MSL Technology Survey (2020)
With physical distancing currently the norm, MSLs must radically change their working practice to effectively engage with KOLs Face-to-face meetings are the preferred choice of MSLs when sharing key scientific...
Compare
Learn More
Injectables and Implantables
Injectables and implantables are key to advancing patient centricity and adherence The development of controlled and prolonged release injectable and implantable drugs has seen huge leaps forward in recent years...
Compare
Learn More
The Digitisation of Diabetes: Opportunities and Challenges for Industry
Assessing the revolutionary impact of digital technologies on the management of diabetes Advanced digital technologies and devices are driving fundamental change in the management of both Type 1 and 2...
Compare
Learn More
AI in Medical Diagnostics
Evaluating the potential of artificial intelligence to revolutionise and expand medical diagnostics Artificial intelligence (AI) driven technologies have already radically changed practice and outcomes in medical...
Compare
Learn More
Health Insurance Disruptors: Going Digital
Health insurance: how to thrive in an increasingly digital health world Health insurers are being challenged to develop a portfolio of digital services with limited knowledge of their effectiveness and at a considerable...
Compare
Learn More
Innovative drugs: Mapping the Pricing and Reimbursement Landscape (2020)
Drug innovation is delivering highly-effective medicines that significantly improve patient outcomes and, in some cases, are curative of disease. Yet of the 55 medicines that were approved in the US between January 2018...
Compare
Learn More
Interoperability in Health
Experts agree interoperability will unlock considerable value across healthcare Interoperability—enabling information systems to share data—offers a wealth of opportunities for multiple health stakeholders,...
Compare
Learn More
Pricing Transparency in Pharma
Pharma challenged to engage and shape the drug pricing transparency debate Anxieties about rising drug prices is fuelling an ever louder global demand for price transparency—and reformers are getting their message...
Compare
Learn More
Regulating Digital Health
As digital health progressively enters mainstream therapy, how should it be regulated and to what outcome? Digital health is booming and as investment in digital health technology grows more products and services will...
Compare
Learn More
The Future of Disease Interception
What does pharma need to do to develop this radical health model of the future? Disease interception is a novel healthcare model that identifies, treats and sometimes cures disease before it is fully manifested. There...
Compare
Learn More
The Future of Personalised Medicine: The Role of Simulation and Digital Twins
Beyond the hype, where might simulation and digital twin technology deliver value for pharma? There is considerable excitement about the potential for simulation and digital twin technology to drive the personalised...
Compare
Learn More
The Future of Virtual Healthcare
What strategy should pharma be pursuing in virtual healthcare? Applications for virtual healthcare engagement are quickly evolving beyond websites and apps towards advanced tools such as virtual assistants and virtual...
Compare
Learn More
The Impact of 5G on Healthcare
Health insurance: how to thrive in an increasingly digital health world 5G wireless network technology has the potential to revolutionize pharma's business. Combined with advances in artificial intelligence and machine...
Compare
Learn More
Financing High-Cost Therapies through Reinsurance
Could reinsurance allay health insurers' fear about high cell and gene therapy costs? With the prospect of many cell and gene therapies coming to market in the medium term, often with record breaking list prices and...
Compare
Learn More
The Impact of Drug Compounding on Pharma
Drug compounding meets unmet clinical needs, widens therapy choice and expands patient access to medicines. What are the lessons and opportunities for pharma? Drug compounding is a fast growing sector meeting the needs...
Compare
Learn More
The Future of CRISPR
Where will CRISPR deliver real value? Investors and pharma are enthusiastic about CRISPR gene editing technology: not only can it be used to develop new therapeutics, it has become a powerful tool in drug discovery,...
Compare
Learn More
Virtual Clinical Trials: The future of drug development?
How viable are virtual clinical trials as a model for conducting clinical research? With our deepening understanding of disease and ever more targeted therapies, slow and costly traditional clinical trials alone are no...
Compare
Next »
Pages:
1
2
3
4
About Us
Contact Us
Privacy Policy
customer.service@firstwordpharma.com
All Contents Copyright © 2021 Doctor's Guide Publishing Limited All Rights Reserved